Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 3.925
-0.025 (-0.63%)
Sep 5, 2025, 5:05 PM GMT+1
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 27.37 million as of September 5, 2025. Its market cap has decreased by -56.22% in one year.
Market Cap
27.37M
Enterprise Value
19.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.93
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 27.37M, a decrease of -49.09%. That is a compound annual growth rate of -15.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 27.37M | -22.92% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | 53.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |